Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2021 09:30 ET | Source: Vivos Inc.

Vivos Inc. Files Early Feasibility IDE Application with FDA for Radiogel™

Richland WA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. is pleased to announce that it has submitted the IDE, Investigational Device Exemption for The Early Feasibility...
January 13, 2020 07:30 ET | Source: Vivos Inc.

Vivos Inc. Provides 2019 Recap and Outlines 2020 Objectives

Richland WA, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), provides 2019 recap and outlines future objectives. Vivos’ CEO, Dr. Mike Korenko stated, “as we begin 2020, I think it is...
December 03, 2019 07:00 ET | Source: Vivos Inc.

Vivos Inc. Treats Additional Patients at its Pilot Clinic

Richland WA, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced that two dogs with different cancer types were treated using Vivos Inc.’s Isopet® therapy on November 27 at...
September 24, 2018 07:00 ET | Source: Vivos Inc.

Vivos Inc Signs a Standstill Agreement with Debt Holders Designed to Halt the Toxic Selling and Eliminate the Secured Toxic Debt

Richland WA , Sept. 24, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to announce that all the debtholders of Vivos’ secured convertible debt have agreed to a ten...
May 31, 2018 06:00 ET | Source: Vivos Inc.

Vivos Inc Successfully Treats Canine Sarcoma with IsoPet™ (RadioGel™)

Richland, WA, May 31, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) successfully treated canine soft tissue sarcoma with its proprietary IsoPet™ (RadioGel™), a hydrogel liquid containing tiny...
May 01, 2018 09:00 ET | Source: Vivos Inc.

Vivos Demonstrates that IsoPet™ (RadioGel™) is effective in killing cancer in cats

Richland, WA, May 01, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today the results from the therapy for feline sarcoma. Five cats were treated at Washington...
March 20, 2018 09:30 ET | Source: Vivos Inc.

Vivos Adds Commercial Expertise to its Veterinary Medicine Advisory Board

Richland, WA, March 20, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it added a new member on the Veterinary Medicine Advisory Board. Tariq Shah BSc. DipMS is the...
January 30, 2018 09:00 ET | Source: Vivos Inc.

Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy

Richland, WA, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) announced today that it has been notified by the FDA that RadioGel™ is classified as a device for animal therapy. ...
November 17, 2017 06:45 ET | Source: Advanced Medical Isotope Corporation

Advanced Medical Isotope Corporation (ADMD) Refines Strategy to Accelerate Penetration of Veterinary Market

RICHLAND, WA, Nov. 17, 2017 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTC PINK: ADMD), a late-stage radiation oncology-focused medical device company, is initially focusing its...